A plateau in pre-Alzheimer memory decline: evidence for compensatory mechanisms?
- PMID: 17620545
- DOI: 10.1212/01.wnl.0000265594.23511.16
A plateau in pre-Alzheimer memory decline: evidence for compensatory mechanisms?
Abstract
Objective: To compare logistic and bilogistic models to describe the pattern of cognitive decline in the preclinical phase of Alzheimer disease (AD).
Methods: We conducted mixed effects modeling of Mayo Cognitive Factors Scores to determine the longitudinal pattern of cognitive decline in the period 10 years prior to and 5 years following a clinical diagnosis of AD. Our analysis included 199 people that eventually received a diagnosis of clinically probable AD. Participants had at least two neuropsychological evaluations including one before the evaluation at which they received the AD diagnosis.
Results: A bilogistic model, including terms for a plateau in the course of cognitive decline, better fit longitudinal memory scores than a simple logistic model. On average the plateau began about 4 years prior to the clinical diagnosis of AD and ended with a decline that probably contributed to the clinical diagnosis of AD. A similar plateau was not evident in four other cognitive domains.
Conclusions: The current findings may support proposed compensatory hypotheses involving redundant memory systems, up-regulation of neurotransmitters, or recruitment of other neural networks.
Similar articles
-
Prodromal Alzheimer's disease: successive emergence of the clinical symptoms.Ann Neurol. 2008 Nov;64(5):492-8. doi: 10.1002/ana.21509. Ann Neurol. 2008. PMID: 19067364
-
Neuropsychological tests accurately predict incident Alzheimer disease after 5 and 10 years.Neurology. 2005 Jun 14;64(11):1853-9. doi: 10.1212/01.WNL.0000163773.21794.0B. Neurology. 2005. PMID: 15955933
-
Identification of Alzheimer disease risk by functional magnetic resonance imaging.Arch Neurol. 2005 Dec;62(12):1881-8. doi: 10.1001/archneur.62.12.1881. Arch Neurol. 2005. PMID: 16344346
-
Cognitive reserve and Alzheimer disease.Alzheimer Dis Assoc Disord. 2006 Apr-Jun;20(2):112-7. doi: 10.1097/01.wad.0000213815.20177.19. Alzheimer Dis Assoc Disord. 2006. PMID: 16772747 Review.
-
Concept of functional imaging of memory decline in Alzheimer's disease.Methods. 2008 Apr;44(4):304-14. doi: 10.1016/j.ymeth.2007.02.002. Methods. 2008. PMID: 18374274 Review.
Cited by
-
Repetitive Transcranial Magnetic Stimulation in the Treatment of Alzheimer's Disease and Other Dementias.Healthcare (Basel). 2021 Jul 28;9(8):949. doi: 10.3390/healthcare9080949. Healthcare (Basel). 2021. PMID: 34442086 Free PMC article. Review.
-
Downregulation of CD73/A2AR-Mediated Adenosine Signaling as a Potential Mechanism of Neuroprotective Effects of Theta-Burst Transcranial Magnetic Stimulation in Acute Experimental Autoimmune Encephalomyelitis.Brain Sci. 2021 Jun 1;11(6):736. doi: 10.3390/brainsci11060736. Brain Sci. 2021. PMID: 34205965 Free PMC article.
-
If ineffective levels of transforming growth factors and their receptor account for old age being a risk factor for Alzheimer's disease, then increasing TGFBR2 might be therapeutic.Alzheimers Dement (N Y). 2020 May 6;6(1):e12019. doi: 10.1002/trc2.12019. eCollection 2020. Alzheimers Dement (N Y). 2020. PMID: 32382652 Free PMC article.
-
Using an Overlapping Time Interval Strategy to Study Diagnostic Instability in Mild Cognitive Impairment Subtypes.Brain Sci. 2019 Sep 19;9(9):242. doi: 10.3390/brainsci9090242. Brain Sci. 2019. PMID: 31546979 Free PMC article.
-
Animal Models of Psychosis in Alzheimer Disease.Am J Geriatr Psychiatry. 2020 Jan;28(1):1-19. doi: 10.1016/j.jagp.2019.05.009. Epub 2019 May 17. Am J Geriatr Psychiatry. 2020. PMID: 31278012 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical